HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetic-pharmacodynamic relationships and dose response to meloxicam in horses with induced arthritis in the right carpal joint.

AbstractOBJECTIVE:
To determine pharmacokinetic-pharmacodynamic (PK-PD) relationships and dose effects for meloxicam in horses and to propose a suitable dosage for use in clinical studies.
ANIMALS:
6 adult horses.
PROCEDURE:
The study was conducted by use of a randomized, Latin-square design. Arthritis was induced in the right carpal joint of each horse by administration of Freund's complete adjuvant. Various dosages of meloxicam (0, 0.25, 0.5, 1.0, and 2.0 mg/kg, IV) were then administered. Validated endpoints including stride length and overall clinical lameness score (scale of 0 to 20) were used to assess the effect of meloxicam. The dose-effect relationship was quantified by use of a maximum possible effect (Emax) model.
RESULTS:
For stride length (expressed as a relative percentage increase from control values), the median effective dose (ED50) was 0.120 mg/kg for an Emax of 11.15%. For clinical lameness score (expressed as an absolute increase from the control value), the ED50 was 0.265 mg/kg for an Emax of 9.16 units. The PK-PD analysis allowed calculation of a median effective concentration of 130 ng/mL for stride length and 195 ng/mL for lameness score. Use of the Emax model predicted a maximal possible increase in effect of 19.5% for stride length and 13.91 units for lameness score. For stride length and lameness score, the Hill coefficient (slope) was extremely high, which suggested a steep dose-effect relationship.
CONCLUSIONS AND CLINICAL RELEVANCE:
Results of this study suggest that meloxicam is a potent anti-inflammatory drug in horses. A dosage of 0.6 mg/kg/d would be appropriate for use in a clinical study.
AuthorsPierre-Louis Toutain, Corinne C Cester
JournalAmerican journal of veterinary research (Am J Vet Res) Vol. 65 Issue 11 Pg. 1533-41 (Nov 2004) ISSN: 0002-9645 [Print] United States
PMID15566092 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Thiazines
  • Thiazoles
  • Meloxicam
Topics
  • Animals
  • Arthritis, Experimental (drug therapy, veterinary)
  • Biomechanical Phenomena
  • Chromatography, High Pressure Liquid
  • Dose-Response Relationship, Drug
  • Endpoint Determination (veterinary)
  • Horse Diseases (metabolism)
  • Horses
  • Lameness, Animal (metabolism)
  • Meloxicam
  • Models, Biological
  • Thiazines (blood, pharmacokinetics, therapeutic use)
  • Thiazoles (blood, pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: